Cytovale Fuels Sepsis Diagnostic Innovation with $84M in Funding
What You Should Know:
Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced it has raised $84 million in Series C funding led by Norwest…
Continue Reading